What a GoodRx coupon actually does for tirzepatide — it works on brand-name Mounjaro and Zepbound, not on compounded — and how it stacks up against other cash-pay routes.
GoodRx is a free discount-coupon service for FDA-approved medications at retail pharmacies. It applies to brand-name tirzepatide (Mounjaro and Zepbound) — not to compounded tirzepatide, which is dispensed cash-pay outside the retail-coupon system.
| Option | Type | From / month | FDA status |
|---|---|---|---|
| Mounjaro® with GoodRx | Brand (T2D) | $900–$1,060/mo | FDA-approved |
| Zepbound® with GoodRx | Brand (weight) | varies; often ~$950–$1,080/mo | FDA-approved |
| Zepbound® LillyDirect self-pay (usually cheaper) | Brand | $299–$449/mo | FDA-approved |
| Compounded tirzepatide (GoodRx N/A) | Compounded | $186/mo (NexLife)* | Not FDA-approved |
GoodRx prices vary by pharmacy and ZIP and change frequently — check GoodRx for your area. For brand Zepbound, LillyDirect self-pay is often lower than a GoodRx coupon.
Because compounded tirzepatide is not an FDA-approved retail product, GoodRx coupons don't apply to it. If you're seeking the lowest cash cost for tirzepatide, compare a GoodRx-discounted brand price against the LillyDirect self-pay program and against flat-rate compounded programs. See cheapest tirzepatide online.
GoodRx coupons apply to brand-name tirzepatide (Mounjaro and Zepbound) at retail pharmacies, typically reducing Mounjaro to about $900–$1,060/month. They do not apply to compounded tirzepatide. See NexLife pricing
Often no — LillyDirect's Self Pay Journey Program ($299–$449/mo) is frequently lower than a GoodRx-discounted Zepbound price. Compare both for your situation.
No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.